nsc 65346 has been researched along with Lymphoma, Primary Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimuro, M; Ishimaru, H; Ishiura, Y; Watanabe, T | 1 |
| Fujimuro, M; Higashi, C; Kagawa, H; Ohga, R; Shigemi, Z; Taira, T; Takadama, T; Ui, S; Wakao, K; Watanabe, T | 1 |
2 other study(ies) available for nsc 65346 and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Isothiocyanates; Leupeptins; Lymphoma, Primary Effusion; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidine Nucleosides; Sulfoxides | 2019 |
Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Topics: Apoptosis; Blotting, Western; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Herpesvirus 8, Human; Host-Pathogen Interactions; Humans; Lymphoma, Primary Effusion; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Pyrimidine Nucleosides; Reverse Transcriptase Polymerase Chain Reaction | 2014 |